New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

XHEvsPBEETF Comparison

ETF 1
XHE

SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
-0.51%
Full XHE fund page
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
-0.26%
Full PBE fund page

SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. XHE is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.58% for PBE. XHE is down -7.18% year-to-date (YTD) with -$4M in YTD flows. PBE performs better with -3.89% YTD performance, and +$135K in YTD flows. Run a side-by-side ETF comparison of XHE and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHE vs PBE performance and flow charts

Performance

-6.0-4.0-2.00.02.0%Feb 10Feb 18Feb 25Mar 4

Cumulative Flows

-3.5 M-3 M-2.5 M-2 M-1.5 M-1 M-0.5 M0 MFeb 10Feb 18Feb 25Mar 4

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/10/2026
1M3MYTD1Y3Y5Y
Perf.
XHE
PBE
-5.57%-3.57%
-8.58%-1.26%
-7.18%-3.89%
-2.13%+20.46%
-6.66%+31.83%
-30.59%+10.46%
Flows
XHE
PBE
--$3M
-$4M+$969K
-$4M+$135K
-$44M-$32M
-$295M-$56M
-$430M-$39M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHE
PBE
+18.92%+18.21%
+23.53%+22.16%
+21.08%+20.15%
+24.18%+22.81%
Max drawdown
XHE
PBE
-12.38%-9.23%
-14.34%-16.18%
-32.63%-22.21%
-49.90%-34.74%
Max drawdown duration
XHE
PBE
61d62d
241d107d
1052d324d
1650d1540d
Trading data

Create an account to view trading data

Join for free
XHE
PBE
Last sale
3/11/2026 at 1:30 PM
$82.04
$78.26
Previous close
03/10/2026
$81.73
$78.82
Consolidated volume
03/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHE
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/11/2026 at 1:30 PM
Live
Closed
XHE
PBE
Last price
$82.04
$78.26
1D performance
+0.38%
-0.71%
AuM$139.06 M$249.34 M
E/R0.35%0.58%
Characteristics
XHE
PBE
Management strategyPassivePassive
ProviderSPDRInvesco
BenchmarkS&P Health Care Equipment Select Industry IndexDynamic Biotech & Genome Intellidex Index
N° of holdings6130
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2011June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

XHE
USA
92.71%
Other
7.29%
PBE
USA
94.25%
Other
5.75%

Sectors

XHE
Health Care
93.87%
Other
6.13%
PBE
Health Care
96.95%
Other
3.05%
Advertisement

Diversification

XHE

Total weight of top 15 holdings out of 15

30.47%
PBE

Total weight of top 15 holdings out of 15

61.48%

Top 15 holdings

Data as of January 31, 2026
XHE
NEOGEN
2.63%
INTEGER HOLDINGS
2.17%
PENUMBRA
2.12%
UFP TECHNOLOGY
2.11%
AXOGEN
2.09%
OMNICELL
1.98%
LANTHEUS HOLDINGS
1.98%
BAXTER INTL
1.98%
GLAUKOS
1.97%
DEXCOM
1.94%
DENTSPLY SIRONA
1.92%
BUTTERFLY NETWORK INC
1.92%
ENVISTA HOLDINGS CORP
1.91%
STRYKER
1.88%
GLOBUS MEDICAL
1.86%
PBE
ILLUMINA
5.91%
GILEAD SCIENCES
5.35%
AMGEN-T
5.09%
REGENERON PHARMACEUTICALS
4.87%
UTD THERAPEUT
4.83%
BIOGEN INC
4.76%
INCYTE
4.70%
ALNYLAM PHARMACEUTICALS
4.05%
AMICUS THERAPEUTICS
3.83%
DYNAVAX TECHNOLOGIES
3.60%
NL0015002SN0
3.05%
ACADIA PHARMACEUTICALS
2.98%
MANNKIND
2.89%
BIO-TECHNE CORP
2.83%
EXELIXIS
2.74%
Frequently asked questions about XHE and PBE

How have the XHE and PBE ETFs performed in 2026?

As of March 10, 2026, XHE is down -7.18% year-to-date (YTD), while PBE has lost -3.89%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or PBE?

Year-to-date, the XHE ETF saw -$4M in flows, compared to +$135K for PBE.

Which ETF is more volatile: XHE or PBE?

Over the past year, XHE had a volatility of 23.53%, while PBE experienced 22.16%.

Which ETF is bigger: XHE or PBE?

As of March 10, 2026, XHE holds $139.06 M in assets under management (AUM), while PBE manages $249.34 M.

What sectors do the XHE and PBE ETFs invest in?

XHE leans toward sectors like Health Care. Meanwhile, PBE focuses on Health Care.

What are the top holdings of the XHE ETF and PBE ETF?

XHE top holdings include NEOGEN, INTEGER HOLDINGS and PENUMBRA. PBE holds in its top three: ILLUMINA, GILEAD SCIENCES and AMGEN-T.

Which ETF is more diversified: XHE or PBE?

XHE holds 64 securities with 30.47% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 61.48%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up